Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Mehr anzeigen
‒ Q3 2024 Net Revenue of $702 million; GAAP Net Loss of $0.2 million; Diluted Loss per Share of $0.00 ‒ ‒ Adjusted EBITDA of $158 million; Adjusted Diluted EPS of $0.16 ‒ ‒ Affirms 2024 Full...
Pyridostigmine Bromide Extended Release is a once-daily soman nerve agent pretreatment pyridostigmine product for the U.S. Armed Services and U.S. allies developed utilizing Amneal’s GRANDE® drug...
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to market open. The Company...
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera’s portfolio of novel injectable and oral development programs...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1513 | 1.85644171779 | 8.15 | 9.475 | 7.52 | 1565515 | 9.04763758 | CS |
| 4 | -0.1587 | -1.87588652482 | 8.46 | 9.475 | 7.52 | 1097564 | 8.6803261 | CS |
| 12 | 0.1913 | 2.3588162762 | 8.11 | 9.475 | 7.52 | 1129003 | 8.59494558 | CS |
| 26 | 1.4513 | 21.1868613139 | 6.85 | 9.475 | 6.29 | 1246685 | 7.7325316 | CS |
| 52 | 2.4213 | 41.1785714286 | 5.88 | 9.475 | 5.01 | 1373634 | 6.80117871 | CS |
| 156 | 2.4213 | 41.1785714286 | 5.88 | 9.475 | 5.01 | 1373634 | 6.80117871 | CS |
| 260 | 2.4213 | 41.1785714286 | 5.88 | 9.475 | 5.01 | 1373634 | 6.80117871 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
